<DOC>
	<DOC>NCT01891292</DOC>
	<brief_summary>The purpose of this study is to determine whether enalapril or antioxidant therapy (N-Acetylcysteine) is effective in reducing microalbuminuria in children with sickle cell disease and and its progression to sickle nephropathy</brief_summary>
	<brief_title>Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Homozygous S sickle cell disease Diagnosed by newborn screening determined to have persistent microalbuminuria satisfied criteria for microalbuminuria screening parental consent Asymptomatic bacteriuria on screening urine cultures On Hydroxyurea therapy Preexisting complications of SCD which would meet local criteria for HU therapy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>